Acer therapeutics plans clinical trial for edsivo™ (celiprolol) following type b fda meeting

Phase 3, randomized, double-blind, placebo-controlled, decentralized clinical trial estimated to take approximately 3.5 years to complete once fully enrolled
ACER Ratings Summary
ACER Quant Ranking